Mitotic Checkpoint Imbalances in Familiar Cancer.
暂无分享,去创建一个
[1] C. Greenwood,et al. Germline Missense Variants in CDC20 Result in Aberrant Mitotic Progression and Familial Cancer , 2021, bioRxiv.
[2] Shixiang Wang,et al. Pan-cancer noncoding genomic analysis identifies functional CDC20 promoter mutation hotspots , 2021, iScience.
[3] Takashi Sasaki,et al. Premature aging syndrome showing random chromosome number instabilities with CDC20 mutation , 2020, Aging cell.
[4] David J. Barry,et al. APC/C Dysfunction Limits Excessive Cancer Chromosomal Instability. , 2017, Cancer discovery.
[5] C. Swanton,et al. The Role of Aneuploidy in Cancer Evolution. , 2017, Cold Spring Harbor perspectives in medicine.
[6] Lauren M. Zasadil,et al. Chromosome missegregation rate predicts whether aneuploidy will promote or suppress tumors , 2013, Proceedings of the National Academy of Sciences.
[7] M. Malumbres. Oncogene-induced mitotic stress: p53 and pRb get mad too. , 2011, Cancer cell.
[8] M. Malumbres,et al. Targeting mitotic exit leads to tumor regression in vivo: Modulation by Cdk1, Mastl, and the PP2A/B55α,δ phosphatase. , 2010, Cancer cell.
[9] Pumin Zhang,et al. Loss of Cdc20 Causes a Securin-Dependent Metaphase Arrest in Two-Cell Mouse Embryos , 2007, Molecular and Cellular Biology.
[10] Bert Vogelstein,et al. Mutations of mitotic checkpoint genes in human cancers , 1998, Nature.